Sp Asset Management Moderna, Inc. Transaction History

Sp Asset Management

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$225.82 - $368.51 $135,492 - $221,106	-600 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$221.9 - $484.47 $2,219 - $4,844	-10 Reduced 1.64%	600 $205,000
Q2 2021 Jul 28, 2021	BUY	$129.91 - $234.98 $79,245 - $143,337	610 New	610 $200,000

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Sp Asset Management, based on Form 13F filings with the SEC.

Stay updated on Sp Asset Management with notifications on news.